Related Experiment Video
Updated: Aug 8, 2026

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
Immunophenotyping specimens from HIV-infected persons: laboratory guidelines from the Centers for Disease Control and
1Immunology Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333.
Insights
The Centers for Disease Control and Prevention (CDC) released new laboratory guidelines for counting CD4+ T-cells in individuals with human immunodeficiency virus (HIV). These guidelines aim to enhance the quality and reliability of lymphocyte immunophenotyping results.
Area of Science:
- Clinical laboratory science
- Immunology
- Virology
Background:
- Accurate enumeration of CD4+ T-cells is crucial for managing human immunodeficiency virus (HIV) infection.
- Existing laboratory practices for lymphocyte immunophenotyping can vary, impacting result reliability.
- The Centers for Disease Control and Prevention (CDC) has historically provided guidance for laboratory testing.
Purpose of the Study:
- To present updated laboratory guidelines for CD4+ T-cell enumeration in HIV-infected individuals.
- To address new data clarifying variables within the immunophenotyping process.
- To improve the quality and consistency of lymphocyte immunophenotyping.
Main Methods:
- Review and synthesis of new data related to immunophenotyping.
- Inclusion of updated information on hematology and immunophenotyping procedures.
- Emphasis on critical quality control parameters for reliable results.
Main Results:
- Publication of comprehensive laboratory guidelines by the CDC.
- Clarification of key variables affecting immunophenotyping accuracy.
- Identification of essential quality control measures for consistent laboratory performance.
Conclusions:
- Adherence to these guidelines will improve the quality of CD4+ T-cell enumeration.
- Enhanced quality control ensures more reliable diagnostic and monitoring information for HIV patients.
- These updated guidelines support standardized and high-quality laboratory practices in HIV care.
Abstract:
The Centers for Disease Control and Prevention has published laboratory guidelines for enumerating CD4+ T-cells from human immunodeficiency virus (HIV)-infected persons to help improve the quality of lymphocyte immunophenotyping. New data that clarify some of the variables in the process of immunophenotyping have been obtained. These include information relevant to both hematology and immunophenotyping procedures as well as quality control parameters that are important in producing reliable results.
More Related Videos
09:26In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 16, 2013
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019